Theratechnologies Inc. (THTX:NASDAQ) closed at $3.39 on July 7, 2026, unchanged on the day. The stock trades 0.3% below its 52-week high of $3.40 and 202.7% above its 52-week low of $1.12. Theratechnologies Inc. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, THTX closed higher on 0 days (0%). Its best day was October 22, 2025 (0.00%) and its worst was October 22, 2025 (0.00%). It never moved 10% or more in a single session.
Theratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. The company mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Find more stocks like THTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.